lamivudine has been researched along with Leukemia, Hairy Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ciancia, R; Martinelli, V; Montante, B; Orlando, R; Piazza, M; Portella, G; Rotoli, B; Tiseo, D; Tosone, G | 1 |
1 other study(ies) available for lamivudine and Leukemia, Hairy Cell
| Article | Year |
|---|---|
Severe reactivation of hepatitis B virus infection in a patient with hairy cell leukemia: Should lamivudine prophylaxis be recommended to HBsAg-negative, anti-HBc-positive patients?
Topics: Aged; Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Leukemia, Hairy Cell; Male; Virus Activation | 2006 |